Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 24% ± 7% | |
glutamatergic neuron | 3 studies | 24% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of KY at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 97% | 240.21 | 631 / 653 | 64% | 2.26 | 385 / 605 |
adrenal gland | 93% | 343.83 | 239 / 258 | 61% | 2.68 | 141 / 230 |
brain | 91% | 114.91 | 2416 / 2642 | 38% | 1.32 | 269 / 705 |
uterus | 88% | 197.41 | 149 / 170 | 10% | 0.58 | 44 / 459 |
skin | 73% | 445.41 | 1326 / 1809 | 3% | 0.10 | 15 / 472 |
prostate | 60% | 66.89 | 148 / 245 | 14% | 0.28 | 71 / 502 |
ovary | 49% | 44.49 | 89 / 180 | 14% | 0.40 | 60 / 430 |
heart | 61% | 141.58 | 529 / 861 | 0% | 0 | 0 / 0 |
intestine | 54% | 73.31 | 526 / 966 | 2% | 0.06 | 12 / 527 |
bladder | 52% | 60.71 | 11 / 21 | 2% | 0.04 | 10 / 504 |
esophagus | 38% | 53.89 | 542 / 1445 | 13% | 0.40 | 24 / 183 |
breast | 43% | 52.62 | 196 / 459 | 7% | 0.15 | 78 / 1118 |
stomach | 40% | 86.12 | 145 / 359 | 8% | 0.20 | 24 / 286 |
blood vessel | 48% | 34.49 | 641 / 1335 | 0% | 0 | 0 / 0 |
muscle | 46% | 161.79 | 372 / 803 | 0% | 0 | 0 / 0 |
kidney | 17% | 9.39 | 15 / 89 | 11% | 0.26 | 96 / 901 |
eye | 0% | 0 | 0 / 0 | 23% | 0.42 | 18 / 80 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.30 | 6 / 45 |
peripheral blood | 12% | 7.54 | 110 / 929 | 0% | 0 | 0 / 0 |
lung | 1% | 0.43 | 5 / 578 | 7% | 0.14 | 81 / 1155 |
pancreas | 0% | 0 | 0 / 328 | 6% | 0.17 | 11 / 178 |
adipose | 3% | 2.30 | 42 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.02 | 3 / 406 |
spleen | 0% | 0.15 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0007517 | Biological process | muscle organ development |
GO_0005856 | Cellular component | cytoskeleton |
GO_0030018 | Cellular component | Z disc |
GO_0005737 | Cellular component | cytoplasm |
GO_0008233 | Molecular function | peptidase activity |
Gene name | KY |
Protein name | Kyphoscoliosis peptidase Kyphoscoliosis peptidase (EC 3.4.-.-) |
Synonyms | |
Description | FUNCTION: Probable cytoskeleton-associated protease required for normal muscle growth. Involved in function, maturation and stabilization of the neuromuscular junction. May act by cleaving muscle-specific proteins such as FLNC (By similarity). . |
Accessions | ENST00000423778.7 [Q8NBH2-4] ENST00000503669.1 ENST00000508956.5 [Q8NBH2-3] Q8NBH2 B4DGA7 |